Unknown

Dataset Information

0

Discovery of novel α-amylase inhibitors using structure-based drug design

ABSTRACT:

SUBMITTER: Al-Asri J 

PROVIDER: S-EPMC3980051 | biostudies-literature | 2014 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Activity prediction, structure-based drug design, molecular docking, and pharmacokinetic studies of 1,4-dihydropyridines derivatives as α-amylase inhibitors.
| S-EPMC10793175 | biostudies-literature
Unknown Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design.
| S-EPMC7745413 | biostudies-literature
Unknown Drug Discovery for Mycobacterium tuberculosis Using Structure-Based Computer-Aided Drug Design Approach.
| S-EPMC8703488 | biostudies-literature
Unknown Structure-Based Drug Design of Novel Heterocyclic Scaffolds as TgCDPK1 Inhibitors.
| S-EPMC12402975 | biostudies-literature
Unknown Discovery of novel choline acetyltransferase inhibitors using structure-based virtual screening.
| S-EPMC5701137 | biostudies-literature
Unknown Discovery of potent inhibitors of α-synuclein aggregation using structure-based iterative learning.
| S-EPMC11062903 | biostudies-literature
Unknown Structure-Based Drug Design Studies Toward the Discovery of Novel Chalcone Derivatives as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors.
| S-EPMC6321200 | biostudies-literature
Unknown Novel inhibitors targeting Venezuelan equine encephalitis virus capsid protein identified using In Silico Structure-Based-Drug-Design.
| S-EPMC5735092 | biostudies-literature
Unknown Discovery of Novel Pyrrolidine-Based Chalcones as Dual Inhibitors of α-Amylase and α-Glucosidase: Synthesis, Molecular Docking, ADMET Profiles, and Pharmacological Screening.
| S-EPMC11904715 | biostudies-literature
Unknown Discovery of inhibitors against SARS-CoV-2 main protease using fragment-based drug design.
| S-EPMC9837207 | biostudies-literature